investment

R&D

LSX USA Jonah Comstock and Eloise McLennan Wrapup

Investment outlook: Key takeaways from LSX USA

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies.

Digital

From PDURS to D2C, Frontiers Health speaks to cutting edge h...

Premiere healthcare innovation event Frontiers Health is just under a month away.

News

Lilly ramps up Irish manufacturing investment by $1bn

Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.

Market Access

Overcoming regulatory hurdles to unleash breakthrough innova...

The life sciences industry is currently undergoing a significant transformation, driven by the rapid development of new modalities such as cell and gene therapies (CAGT), and substantial ne

News

GLP-1 bonanza spurs big investment at CDMO CordenPharma

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.

News

Novo Nordisk's site in Clayton, North Carolina

Novo Nordisk pledges $4.1bn for US injectables plant

Novo Nordisk has gone up another gear in its drive to boost manufacturing capacity for its fast-growing GLP-1 agonist drugs, announcing plans to build a $4.1 billion fill-and-finish facilit

Investment outlook: Key takeaways from LSX USA

From PDURS to D2C, Frontiers Health speaks to cutting edge h...

Lilly ramps up Irish manufacturing investment by $1bn

Overcoming regulatory hurdles to unleash breakthrough innova...

GLP-1 bonanza spurs big investment at CDMO CordenPharma

Novo Nordisk pledges $4.1bn for US injectables plant

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

investment

Editor's Picks